 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Chugai Pharmaceutical Co., Ltd.
 |
Chugai Pharmaceutical Co., Ltd. |
 |
 |
 |
PROFILE |
 |
Chugai Pharmaceutical develops therapies for bone metabolism and blood disorders, cancer, infectious diseases, and cardiovascular and brain diseases. Products include Granocyte (marketed as Neutrogin in Japan), which treats white blood cell loss related to chemotherapy, and Epogin, which treats red blood cell loss caused by chronic kidney failure. Chugai is seeking to expand in the US and Europe through its subsidiaries and through joint ventures with companies such as Eli Lilly. Chugai also seeks to expand its nonprescription products line and diagnostics business (US-based subsidiary Gen-Probe develops tests for the identification of such sexually transmitted diseases as chlamydia and gonorrhea).
COMPETITION |
 |
Amgen Inc. (AMGN)
Immunex Corporation (IMNX)
Takeda Chemical Industries, Ltd. (4502)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
2000 Sales (mil.): 1,853.00
1-Yr. Sales Growth: 18.3%
Employees: 4,630
Revenue per employee: $400,215.98
KEY PEOPLE |
 |
Osamu Nagayama
CEO
Yuji Suzawa
CFO
CONTACT INFO |
 |
1-9, Kyobashi 2-chome, Chuo-ku
Tokyo 104-8301, Japan
Phone: 81-3-3281-6611
Fax: 81-3-3281-2828
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |